Collegium Pharmaceutical Inc (COLL)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 127.01M | 129.62M | 144.77M | 135.55M | 136.71M | 149.75M | 144.92M | 145.28M |
営業利益 | 20.47M | 11.76M | 24.63M | 35.63M | 45.01M | 61.69M | 49.47M | 47.47M |
税引前収入 | 1.43M | -7.79M | -17.56M | 17.8M | 28.78M | 46.71M | 36.62M | 29.1M |
純利益 | 457k | -7.2M | -17.43M | 13.01M | 20.63M | 31.94M | 27.71M | 19.61M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 20.47M | 11.76M | 24.63M | 35.63M | 45.01M | 61.69M | 49.47M | 47.47M |
EBITDA | 58.51M | 54.86M | 62.91M | 73.99M | 82.17M | 97.15M | 84.91M | 82.94M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 1.71M | 28.48M | 280.41M | 296.7M | 310.02M | 276.87M | 463.93M | 566.77M |
営業利益 | -94.08M | -75.45M | -20.69M | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
税引前収入 | -94.18M | -74.87M | -39.13M | -22.72M | 27.58M | -3.37M | -28.85M | 75.73M |
純利益 | -94.18M | -74.87M | -39.13M | -22.72M | 26.75M | 71.52M | -25M | 48.16M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.207 | -2.284 | -1.176 | -0.675 | 0.773 | 1.997 | -0.739 | 1.477 |
EBIT | -94.08M | -75.45M | -20.69M | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
EBITDA | -93.43M | -73.27M | 90.22M | -8.27M | 117.78M | 86.55M | 172.26M | 316.22M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約